Innoviva (INVA) Long-Term Deferred Tax (2011 - 2025)

Innoviva (INVA) reported Long-Term Deferred Tax of $8.0 million for Q3 2025, down 46.34% on a YoY basis from $14.9 million in Q3 2024, and down 38.27% quarter-over-quarter from $12.9 million in Q2 2025.

Innoviva (INVA) Long-Term Deferred Tax (2011 - 2025) Analysis & Trends

Innoviva has reported Long-Term Deferred Tax for 10 years, with the latest figure at $8.0 million in Q3 2025.

  • For the quarter ending Q3 2025, Long-Term Deferred Tax fell 46.34% year-over-year to $8.0 million; the trailing twelve-month figure through Sep 2025 stood at $8.0 million (down 46.34% YoY), and the FY2025 full-year result was $8.0 million, down 46.34% from the prior year.
  • Long-Term Deferred Tax for Q3 2025 stood at $8.0 million, down from $12.9 million in the prior quarter.
  • The five-year high for Long-Term Deferred Tax was $74.0 million in Q1 2021, with the low at $5.0 million in Q3 2023.
  • Historically, Long-Term Deferred Tax has averaged $21.2 million across 5 years, with a median of $13.9 million in 2024.
  • Annual changes were most pronounced in 2021 — Long-Term Deferred Tax slumped 81.52% — and 2024, when it jumped 200.38%.
  • Innoviva's Long-Term Deferred Tax stood at $17.3 million in 2021, then jumped by 34.32% to $23.3 million in 2022, then sank by 78.72% to $5.0 million in 2023, then surged by 143.42% to $12.1 million in 2024, then sank by 33.78% to $8.0 million in 2025.
  • The last three Long-Term Deferred Tax figures came in at $8.0 million (Q3 2025), $12.9 million (Q2 2025), and $12.3 million (Q1 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 814,307.08 Bn 814,307.05 Bn -
2 Belite Bio 55,320.00 Bn 55,320.00 Bn -
3 Quantum Biopharma 17,149.72 Bn 17,149.72 Bn -
4 Legend Biotech 3,590.00 Bn 3,589.71 Bn 242.10 Mn
5 Akari Therapeutics 1,650.72 Bn 1,650.72 Bn -
6 Evaxion A 1,522.09 Bn 1,522.07 Bn -
7 Psyence Biomedical 229.39 Bn 229.38 Bn -
8 Vertex Pharmaceuticals 113.09 Bn 105.85 Bn 2.59 Bn
9 Abivax 90.15 Bn 90.15 Bn -
10 Innoviva 1.69 Bn 1.08 Bn 75.83 Mn

Historic Data

Download Data
DateValue
Sep 30, 2025 7.98 Mn
Jun 30, 2025 12.93 Mn
Mar 31, 2025 12.29 Mn
Dec 31, 2024 12.05 Mn
Sep 30, 2024 14.88 Mn
Jun 30, 2024 11.45 Mn
Sep 30, 2023 4.95 Mn
Jun 30, 2023 6.33 Mn
Jun 30, 2022 23.27 Mn
Mar 31, 2022 22.40 Mn
Dec 31, 2021 17.33 Mn
Sep 30, 2021 28.16 Mn
Jun 30, 2021 48.69 Mn
Mar 31, 2021 74.02 Mn
Dec 31, 2020 93.76 Mn
Sep 30, 2020 109.49 Mn
Jun 30, 2020 118.35 Mn
Mar 31, 2020 138.24 Mn
Dec 31, 2019 154.17 Mn
Sep 30, 2019 166.56 Mn